Siemens Healthineers AG (ETR:SHL)
Germany · Delayed Price · Currency is EUR 39.13
-0.39 (-0.99%)
Aug 31, 2026, 5:35 PM CET
Siemens Healthineers AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 43,555 | 51,212 | 60,096 | 53,731 | 49,516 | 63,053 | |
Market Cap Growth | -17.13% | -14.78% | 11.85% | 8.51% | -21.47% | 53.46% |
Enterprise Value | 56,258 | 64,579 | 74,946 | 68,714 | 63,842 | 76,719 |
Last Close Price | 39.13 | 44.94 | 51.72 | 45.24 | 40.96 | 51.18 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 19.82 | 23.89 | 30.95 | 35.61 | 24.30 | 36.51 |
Forward PE | 17.34 | 18.87 | 23.34 | 21.37 | 19.30 | 26.77 |
PS Ratio | 1.88 | 2.19 | 2.69 | 2.48 | 2.28 | 3.50 |
PB Ratio | 2.27 | 2.83 | 3.29 | 2.96 | 2.49 | 3.93 |
P/FCF Ratio | 16.71 | 18.87 | 28.21 | 41.94 | 29.97 | 27.91 |
P/OCF Ratio | 12.73 | 14.50 | 21.27 | 25.36 | 19.77 | 21.50 |
PEG Ratio | 2.45 | 1.77 | 1.94 | 1.87 | 2.11 | 2.25 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 2.43 | 2.76 | 3.35 | 3.17 | 2.94 | 4.26 |
EV/EBITDA Ratio | 13.32 | 15.85 | 20.06 | 21.28 | 16.20 | 23.20 |
EV/EBIT Ratio | 17.42 | 20.41 | 26.68 | 32.22 | 21.83 | 29.88 |
EV/FCF Ratio | 21.58 | 23.80 | 35.19 | 53.64 | 38.65 | 33.96 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.78 | 0.82 | 0.89 | 0.92 | 0.84 | 0.89 |
Debt / EBITDA Ratio | 3.54 | 3.45 | 4.11 | 4.83 | 4.02 | 4.11 |
Debt / FCF Ratio | 5.76 | 5.45 | 7.61 | 13.00 | 10.08 | 6.34 |
Net Debt / Equity Ratio | 0.66 | 0.70 | 0.74 | 0.79 | 0.77 | 0.81 |
Net Debt / EBITDA Ratio | 3.14 | 3.10 | 3.62 | 4.46 | 3.86 | 3.93 |
Net Debt / FCF Ratio | 4.85 | 4.65 | 6.35 | 11.25 | 9.21 | 5.75 |
Asset Turnover | 0.51 | 0.52 | 0.48 | 0.45 | 0.48 | 0.54 |
Inventory Turnover | 3.10 | 3.45 | 3.28 | 3.37 | 3.78 | 4.03 |
Quick Ratio | 0.71 | 0.75 | 0.85 | 0.68 | 0.71 | 0.73 |
Current Ratio | 1.16 | 1.12 | 1.25 | 1.05 | 1.11 | 1.07 |
Return on Equity (ROE) | 12.15% | 11.93% | 10.77% | 8.03% | 11.45% | 12.22% |
Return on Assets (ROA) | 4.48% | 4.37% | 3.79% | 2.79% | 4.02% | 4.79% |
Return on Invested Capital (ROIC) | 7.90% | 7.69% | 6.78% | 4.99% | 6.69% | 8.04% |
Return on Capital Employed (ROCE) | 9.90% | 10.00% | 8.10% | 6.40% | 7.90% | 8.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | 5.08% | 4.19% | 3.23% | 2.81% | 4.12% | 2.74% |
FCF Yield | 5.99% | 5.30% | 3.54% | 2.38% | 3.34% | 3.58% |
Dividend Yield | 2.50% | 2.23% | 1.84% | 2.10% | 2.32% | 1.66% |
Payout Ratio | 50.52% | 49.72% | 54.74% | 70.64% | 46.86% | 49.57% |
Buyback Yield / Dilution | 0.49% | -0.11% | 0.01% | 0.37% | -2.19% | -9.91% |
Total Shareholder Return | 2.99% | 2.11% | 1.85% | 2.47% | 0.13% | -8.25% |